Investigators compared bariatric surgery with a community weight management intervention in ability to reduce intracranial pressure among patients with idiopathic intracranial hypertension.
Here are highlights from the American Heart Association and American Stroke Association’s 2021 evidence-based guidelines for preventing another stroke after a first stroke or transient ischemic attack.
A team of investigators sought to identify the impact of hyperglycemia on the severity of and outcomes associated with stroke in patients with type 2 diabetes.
HOPE-3 was designed to assess if reducing BP and/or LDL-C would reduce cardiovascular events in study participants at intermediate risk with no prior cardiovascular events.
The association between stroke and obesity in adolescence was examined in a population-based study.
Researchers sought to identify and analyze risk factors for thrombosis in adolescent girls receiving hormonal therapy.
Diabetes is associated with increased risk of vascular conditions, such as ischemic heart disease, stroke, renal, and neuropathic complications. In this featured study, researchers examine how the cause of mortality in diabetes has changed over time.
At the 2021 International Stroke Conference, researchers presented their findings on stroke among men with COVID-19 and high comorbidity burden.
The approval was based on data from the phase 3 ODYSSEY HoFH trial, which evaluated Praluent in 69 adults with HoFH who were on other LDL-C-lowering therapies.
Statins were associated with a reduction in mortality but there was no significant difference in the composite end point with fenofibrates alone or in combination with statins.
